HuagongsheHuagongshe Chemistry Print Report · For research reference only
Buprenorphine component OF alks-5461 → 17-allyl-7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-6alpha,14alpha-ethanomorphinan
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Buprenorphine component OF alks-5461 | HCID 9848990 | — |
| Reactant | 17-cyclopropylmethyl-7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-6alpha,14alpha-ethanomorphinan | HCID 86711659 | — |
| Reactant | 17-allyl-7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14alpha-ethanomorphinan | HCID 86711662 | — |
| Product | 17-allyl-7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-6alpha,14alpha-ethanomorphinan | HCID 86711663 | 75.8% |
Reaction Steps
Compound 16 was synthesized similar to the procedure described in Example 1 for the preparation of compound 2 using compound 15 rather than compound 1. After column chromatography, 4.0 g of compound 16 (75.8%) was obtained with a purity of 98.5%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09315514B2 |
| Source dataset | uspto-grants-2016_04 |
| ORD ID | ord-fde15df01f84463c9c11d56a4c5b73fe |
| Source note | uspto-grants-2016_04 |